Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
about
Integrative systems biology approaches in asthma pharmacogenomicsDrug-gene interactions: inherent variability in drug maintenance dose requirementsFrom expression pattern to genetic association in asthma and asthma-related phenotypes.Can certain genotypes predispose to poor asthma control in children? A pharmacogenetic study of 9 candidate genes in children with difficult asthma.Beta2 adrenergic receptor (ADRβ2) haplotype pair (2/4) is associated with severe asthmaPharmacogenomics of long-acting β2-agonists.A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease.β1-Adrenergic receptor blockade extends the life span of Drosophila and long-lived mice.Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors.Novel cAMP signalling paradigms: therapeutic implications for airway diseaseCurrent treatment of severe asthma.Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management.Pharmacogenetic biomarkers for predicting drug response.Influence of ethnicity on response to asthma drugs.Asthma Pharmacogenomics: 2015 Update.The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference.Vitamin D receptor polymorphisms may contribute to asthma risk.What the Genetic Background of Individuals with Asthma and Obesity Can Reveal: Is β2-Adrenergic Receptor Gene Polymorphism Important?Lung development in children: role of genetic and environmental factors.Effects of genetic factors to inhaled corticosteroid response in children with asthma: a literature review.Pharmacogenetic and pharmacogenomic considerations of asthma treatment.ADRB2 gene polymorphisms and salbutamol responsiveness in Serbian children with asthmaPolymorphism of Beta2-Adrenoceptor and Regular Use of Formoterol in Asthma: Preliminary ResultsBeta2-Adrenergic Receptor Gene Polymorphisms in Egyptian Patients with Acute Myocardial Infarction
P2860
Q26861541-0FF3920E-6E98-4F6D-8127-2EA30417826FQ34154939-DA569D7E-2807-4649-A385-85EE69FEEAC9Q34475635-F2FEBF6C-FA00-4FCC-98F5-29D4F0E136EBQ34662042-76397347-33DC-466F-98EE-ECD733880571Q35137713-04193D69-FA91-4791-95CF-2F4FCB270932Q35734012-24176D5F-83EC-40BE-B5F4-E6020C92D29BQ36844920-3E44F5C8-9588-42D5-AA6E-42056A65DD3CQ37300549-60AC58A0-96B5-491D-8920-E95E8813A7D1Q37595504-89BD02C9-D8AC-4C12-8985-A7F6F5B24D2FQ37947662-0D506070-B3E2-4736-A3BC-6ACF1CF0DE80Q37976485-CBFD6620-63F3-4819-959E-D3FA4E3BA1C7Q38196942-375DF742-B66C-494E-A8A2-39A29765AEBDQ38214388-584C5573-B2A8-4E4B-A542-D3855B00A41AQ38494683-6B6C5877-0966-4FB2-A0C5-7218680A9E9EQ38542847-ADB08557-3A91-4334-8F37-2A6FC7F8F2B4Q38664877-3A97D2A0-62A1-4043-88BD-3FE90FA21B68Q39843075-C45D7118-6131-413F-BD52-C1CE5C61AECFQ42909074-4BDEDB68-B278-4320-B821-F3E946CCA8AEQ44403322-133800DA-B66A-40F5-A380-F05E5F49BAB6Q47678283-255EC849-8A6B-41EC-878F-7E4E5B456D78Q48220346-AC2F9C6D-0A77-4A78-8090-9EFA7A3E7B05Q58695631-6E5B889C-5058-447E-A7C0-FD60FFD5B72BQ58993741-929D7264-16A2-464B-BB17-5BA54EF9B77EQ59049500-BBF36E77-6F7D-4194-8E7B-AFE7A72E7B32
P2860
Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacogenetics of β2 adrener ...... -acting β-agonists and asthma.
@en
Pharmacogenetics of β2 adrener ...... -acting β-agonists and asthma.
@nl
type
label
Pharmacogenetics of β2 adrener ...... -acting β-agonists and asthma.
@en
Pharmacogenetics of β2 adrener ...... -acting β-agonists and asthma.
@nl
prefLabel
Pharmacogenetics of β2 adrener ...... -acting β-agonists and asthma.
@en
Pharmacogenetics of β2 adrener ...... -acting β-agonists and asthma.
@nl
P2093
P2860
P1476
Pharmacogenetics of β2 adrener ...... -acting β-agonists and asthma.
@en
P2093
P J Thompson
P2860
P304
P356
10.1111/J.1365-2222.2011.03696.X
P577
2011-03-01T00:00:00Z